These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 16508734)
41. [Capecitabine]. Yamaguchi K; Shimamura T; Tada M Gan To Kagaku Ryoho; 2006 Jul; 33(7):891-5. PubMed ID: 16835474 [TBL] [Abstract][Full Text] [Related]
42. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer]. Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010 [TBL] [Abstract][Full Text] [Related]
51. Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial). Veerasarn V; Phromratanapongse P; Lorvidhaya V; Lertsanguansinchai P; Lertbutsayanukul C; Panichevaluk A; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Rojanasakul A; Thavichaigarn P; Jivapaisarnpong P J Med Assoc Thai; 2006 Nov; 89(11):1874-84. PubMed ID: 17205868 [TBL] [Abstract][Full Text] [Related]
52. A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer. Lortholary A; Hardy-Bessard AC; Bachelot T; de Rauglaudre G; Alexandre J; Bourgeois H; Jaubert D; Paraiso D; Largillier R Breast Cancer Res Treat; 2012 Jan; 131(1):127-35. PubMed ID: 21947680 [TBL] [Abstract][Full Text] [Related]
53. Results of a phase I study to determine the maximum tolerated dose of capecitabine when given concurrently with radical radiotherapy in the treatment of squamous cell carcinoma of the head and neck. Sykes AJ; Slevin NJ; MacDougall RH; Ironside JA; Mais KL Radiother Oncol; 2004 Apr; 71(1):81-4. PubMed ID: 15066299 [TBL] [Abstract][Full Text] [Related]
54. Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine. Perotti A; Locatelli A; Sessa C; Hess D; Viganò L; Capri G; Maur M; Cerny T; Cresta S; Rojo F; Albanell J; Marsoni S; Corradino I; Berk L; Rivera VM; Haluska F; Gianni L J Clin Oncol; 2010 Oct; 28(30):4554-61. PubMed ID: 20855840 [TBL] [Abstract][Full Text] [Related]
56. Phase I evaluation of telatinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors. Langenberg MH; Witteveen PO; Roodhart JM; Verheul HM; Mergui-Roelvink M; van der Sar J; Brendel E; Laferriere N; Schellens JH; Voest EE Clin Cancer Res; 2010 Apr; 16(7):2187-97. PubMed ID: 20233884 [TBL] [Abstract][Full Text] [Related]
57. A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer. Jin J; Li YX; Liu YP; Wang WH; Song YW; Li T; Li N; Yu ZH; Liu XF Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):725-9. PubMed ID: 16242260 [TBL] [Abstract][Full Text] [Related]
58. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients]. Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765 [TBL] [Abstract][Full Text] [Related]
59. Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion. Tipples K; Kolluri RB; Raouf S J Oncol Pharm Pract; 2009 Dec; 15(4):237-9. PubMed ID: 19276137 [TBL] [Abstract][Full Text] [Related]